Drug-discovery firm nets $14.5M in Series A funding
X-37 leverages AI technology similar to facial recognition to figure out which small molecules can bind most effectively with targeted enzymes.
X-37 leverages AI technology similar to facial recognition to figure out which small molecules can bind most effectively with targeted enzymes.